A Study of Safety, Tolerability, and Pk of rhMBL in Pediatric Hematology/Oncology Pts With Fever and Neutropenia

NCT00520325 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Sponsor decision to terminate the study

Conditions

Cancer
Hematologic Diseases
Fever
Neutropenia

Interventions

DRUG: Intravenous recombinant human mannose binding lectin
DRUG: Intravenous recombinant human mannose binding lectin

Sponsor

Enzon Pharmaceuticals, Inc.